Verition Fund Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,771	Closed	-$588K	–	2368
2023 Q2	$588K	Hold	5,771	–	–	0.01%	990
2023 Q1	$525K	Buy	+5,771	New	+$525K	0.01%	1105
2022 Q2	–	Sell	-83,158	Closed	-$2.72M	–	2502
2022 Q1	$2.72M	Buy	+83,158	New	+$2.72M	0.03%	517